|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6886 | (2018.01) |
| A61K 31/445 | (2013.01) | ||
| C12Q 1/68 | (2018.01) | ||
| G01N 33/57423 | (2013.01) | ||
| G01N 33/574 | (2006.01) | ||
| G01N 33/57426 | (2013.01) | ||
| A61K 48/00 | (2006.01) | ||
| G01N 33/57438 | (2013.01) | ||
| A61K 31/70 | (2006.01) | ||
| G01N2333/91205 | (2013.01) | ||
| A61K 31/445 | (2006.01) | ||
| G01N2800/52 | (2013.01) | ||
| C12Y 207/11023 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/40 | (2006.01) | ||
| C12Y 207/11022 | (2013.01) | ||
| A61K 31/404 | (2006.01) | ||
| C12N 15/1137 | (2013.01) | ||
| A61K 31/44 | (2006.01) | ||
| C12N2310/531 | (2013.01) | ||
| A61K 31/4545 | (2006.01) | ||
| C12N2320/10 | (2013.01) | ||
| C12N2320/30 | (2013.01) | ||
| A61K 31/4745 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/40 | (2013.01) | ||
| A61K 31/404 | (2013.01) | ||
| A61K 31/44 | (2013.01) | ||
| A61K 31/4545 | (2013.01) | ||
| A61K 31/4745 | (2013.01) | ||
| A61K 31/655 | (2013.01) | ||
| A61K 31/7048 | (2013.01) | ||
| A61K 31/7068 | (2013.01) | ||
| C12Q 1/6886 | (2013.01) | ||
| C12Q2600/106 | (2013.01) | ||
| C12Q2600/158 | (2013.01) | ||
| A61K 31/519 | (2013.01) |
| (11) | Number of the document | 3686290 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20157661.8 |
| Date of filing the European patent application | 2015-04-02 | |
| (97) | Date of publication of the European application | 2020-07-29 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201461975401 P | 2014-04-04 | US |
| (72) |
LOWE, Scott, William , US
SHERR, Charles, J. , US
HUANG, Chun-Hao , US
LUJAMBIO, Amaia , US
|
| (73) |
Memorial Sloan-Kettering Cancer Center ,
1275 York Avenue, New York, NY 10065,
US
St. Jude Children's Research Hospital , 262 Danny Thomas Place, Memphis, TN 38105-3678, US |
| (54) | METHOD AND KITS FOR IDENTIFYING CDK9 INHIBITORS FOR THE TREATMENT OF CANCER |
| METHOD AND KITS FOR IDENTIFYING CDK9 INHIBITORS FOR THE TREATMENT OF CANCER |